Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China · Delayed Price · Currency is CNY 3.280
-0.060 (-1.80%)
May 20, 2026, 12:14 PM CST
SHE:300026 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 23.88 | 18.5 | 21.47 | 506.63 | 624.24 | 687.32 |
Depreciation & Amortization | 322.02 | 322.02 | 346.62 | 346.11 | 306.8 | 261.47 |
Other Amortization | 37.09 | 37.09 | 22.02 | 27.09 | 30.31 | 32.14 |
Loss (Gain) From Sale of Assets | -0.7 | -0.7 | -1.08 | -1.06 | -0.01 | 2.87 |
Asset Writedown & Restructuring Costs | 44.58 | 44.58 | 47.67 | 27.57 | 2.36 | 81.71 |
Loss (Gain) From Sale of Investments | 3.66 | 3.66 | 5.63 | 1.4 | -3.16 | 22.98 |
Provision & Write-off of Bad Debts | 62.59 | 62.59 | 100.51 | 54.84 | 74.21 | 85.59 |
Other Operating Activities | 143.75 | 161.71 | 97.93 | 78.28 | 57.76 | 54.13 |
Change in Accounts Receivable | 252.02 | 252.02 | -10.92 | 690.83 | 172.98 | -1,041 |
Change in Inventory | 255.25 | 255.25 | 158.12 | 223.74 | -914.09 | 106.36 |
Change in Accounts Payable | -329.86 | -329.86 | 135.65 | -430.08 | 380.85 | 97.1 |
Change in Other Net Operating Assets | -6.02 | -6.02 | 5.19 | 5.51 | 16.45 | -5.51 |
Operating Cash Flow | 798.77 | 811.34 | 852.24 | 1,530 | 745.35 | 391.6 |
Operating Cash Flow Growth | -2.42% | -4.80% | -44.30% | 105.29% | 90.33% | 99.12% |
Capital Expenditures | -114.63 | -130.25 | -193.12 | -347.12 | -770.27 | -677.45 |
Sale of Property, Plant & Equipment | 0.7 | 0.7 | 0.39 | 1.89 | 0.22 | 2.79 |
Divestitures | - | - | -1.59 | -53.03 | - | 0.21 |
Investment in Securities | 0.62 | 0.66 | 6.79 | -3.13 | 34.72 | 14.73 |
Other Investing Activities | - | 1.54 | - | -1.53 | 6.88 | 17.44 |
Investing Cash Flow | -113.31 | -127.34 | -170.26 | -402.92 | -728.44 | -642.27 |
Long-Term Debt Issued | - | 55.33 | 56.51 | 439.2 | 843.39 | 1,603 |
Total Debt Issued | 54.69 | 55.33 | 56.51 | 439.2 | 843.39 | 1,603 |
Short-Term Debt Repaid | - | - | - | - | - | -0.82 |
Long-Term Debt Repaid | - | -402.37 | -868.3 | -1,044 | -802.29 | -967.76 |
Total Debt Repaid | -265.81 | -402.37 | -868.3 | -1,044 | -802.29 | -968.58 |
Net Debt Issued (Repaid) | -211.12 | -347.04 | -811.79 | -604.34 | 41.1 | 634.9 |
Common Dividends Paid | -102.83 | -105.4 | -137.11 | -154.7 | -190.79 | -157.84 |
Other Financing Activities | -23.28 | -17.58 | -11.74 | -9.46 | -0.92 | -12.26 |
Financing Cash Flow | -337.23 | -470.01 | -960.64 | -768.5 | -150.6 | 464.8 |
Foreign Exchange Rate Adjustments | -9.02 | -3.46 | 4.29 | 5.49 | 22.91 | -6.27 |
Net Cash Flow | 339.2 | 210.53 | -274.37 | 364.17 | -110.78 | 207.85 |
Free Cash Flow | 684.14 | 681.09 | 659.12 | 1,183 | -24.93 | -285.85 |
Free Cash Flow Growth | 8.67% | 3.33% | -44.28% | - | - | - |
Free Cash Flow Margin | 14.62% | 13.78% | 11.40% | 19.36% | -0.38% | -3.73% |
Free Cash Flow Per Share | 0.36 | 0.37 | 0.31 | 0.40 | -0.01 | -0.10 |
Cash Income Tax Paid | 435.92 | 451.99 | 481.3 | 434.17 | 439.93 | 619.4 |
Levered Free Cash Flow | 733.73 | 659.89 | 576.51 | 679.83 | -320.75 | -610.66 |
Unlevered Free Cash Flow | 745.81 | 671.97 | 604.55 | 718.32 | -277.21 | -579.35 |
Change in Working Capital | 161.9 | 161.9 | 211.48 | 489.23 | -347.16 | -836.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.